160 related articles for article (PubMed ID: 32838932)
1. The VSV matrix protein inhibits NF-κB and the interferon response independently in mouse L929 cells.
Marquis KA; Becker RL; Weiss AN; Morris MC; Ferran MC
Virology; 2020 Sep; 548():117-123. PubMed ID: 32838932
[TBL] [Abstract][Full Text] [Related]
2. The vesicular stomatitis virus matrix protein inhibits NF-κB activation in mouse L929 cells.
Varble AJ; Ried CD; Hammond WJ; Marquis KA; Woodruff MC; Ferran MC
Virology; 2016 Dec; 499():99-104. PubMed ID: 27643886
[TBL] [Abstract][Full Text] [Related]
3. Computational prediction of intracellular targets of wild-type or mutant vesicular stomatitis matrix protein.
Morris MC; Russell TM; Lyman CA; Wong WK; Broderick G; Ferran MC
PLoS One; 2022; 17(2):e0263065. PubMed ID: 35108303
[TBL] [Abstract][Full Text] [Related]
4. Interferon-inducible protein IFI35 negatively regulates RIG-I antiviral signaling and supports vesicular stomatitis virus replication.
Das A; Dinh PX; Panda D; Pattnaik AK
J Virol; 2014 Mar; 88(6):3103-13. PubMed ID: 24371060
[TBL] [Abstract][Full Text] [Related]
5. Ability of the matrix protein of vesicular stomatitis virus to suppress beta interferon gene expression is genetically correlated with the inhibition of host RNA and protein synthesis.
Ahmed M; McKenzie MO; Puckett S; Hojnacki M; Poliquin L; Lyles DS
J Virol; 2003 Apr; 77(8):4646-57. PubMed ID: 12663771
[TBL] [Abstract][Full Text] [Related]
6. The vesicular stomatitis virus matrix protein inhibits transcription from the human beta interferon promoter.
Ferran MC; Lucas-Lenard JM
J Virol; 1997 Jan; 71(1):371-7. PubMed ID: 8985359
[TBL] [Abstract][Full Text] [Related]
7. NF-kappaB activation Is delayed in mouse L929 cells infected with interferon suppressing, but not inducing, vesicular stomatitis virus strains.
Boulares AH; Ferran MC; Lucas-Lenard J
Virology; 1996 Apr; 218(1):71-80. PubMed ID: 8615043
[TBL] [Abstract][Full Text] [Related]
8. Signaling pathways in murine dendritic cells that regulate the response to vesicular stomatitis virus vectors that express flagellin.
Smedberg JR; Westcott MM; Ahmed M; Lyles DS
J Virol; 2014 Jan; 88(2):777-85. PubMed ID: 24198430
[TBL] [Abstract][Full Text] [Related]
9. Concomitant TLR/RLH signaling of radioresistant and radiosensitive cells is essential for protection against vesicular stomatitis virus infection.
Spanier J; Lienenklaus S; Paijo J; Kessler A; Borst K; Heindorf S; Baker DP; Kröger A; Weiss S; Detje CN; Staeheli P; Kalinke U
J Immunol; 2014 Sep; 193(6):3045-54. PubMed ID: 25127863
[TBL] [Abstract][Full Text] [Related]
10. Variation in susceptibility of human malignant melanomas to oncolytic vesicular stomatitis virus.
Blackham AU; Northrup SA; Willingham M; D'Agostino RB; Lyles DS; Stewart JH
Surgery; 2013 Mar; 153(3):333-43. PubMed ID: 23102637
[TBL] [Abstract][Full Text] [Related]
11. Translational control of the activation of transcription factor NF-κB and production of type I interferon by phosphorylation of the translation factor eIF4E.
Herdy B; Jaramillo M; Svitkin YV; Rosenfeld AB; Kobayashi M; Walsh D; Alain T; Sean P; Robichaud N; Topisirovic I; Furic L; Dowling RJO; Sylvestre A; Rong L; Colina R; Costa-Mattioli M; Fritz JH; Olivier M; Brown E; Mohr I; Sonenberg N
Nat Immunol; 2012 Apr; 13(6):543-550. PubMed ID: 22544393
[TBL] [Abstract][Full Text] [Related]
12. Methylation of viral mRNA cap structures by PCIF1 attenuates the antiviral activity of interferon-β.
Tartell MA; Boulias K; Hoffmann GB; Bloyet LM; Greer EL; Whelan SPJ
Proc Natl Acad Sci U S A; 2021 Jul; 118(29):. PubMed ID: 34266951
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of human dendritic cells by wild-type and M protein mutant vesicular stomatitis viruses engineered to express bacterial flagellin.
Ahmed M; Puckett S; Arimilli S; Braxton CL; Mizel SB; Lyles DS
J Virol; 2010 Nov; 84(22):12093-8. PubMed ID: 20844045
[TBL] [Abstract][Full Text] [Related]
14. Interferon-induced protein Ifit2 protects mice from infection of the peripheral nervous system by vesicular stomatitis virus.
Fensterl V; Wetzel JL; Sen GC
J Virol; 2014 Sep; 88(18):10303-11. PubMed ID: 24991014
[TBL] [Abstract][Full Text] [Related]
15. Type III interferon attenuates a vesicular stomatitis virus-based vaccine vector.
Guayasamin RC; Reynolds TD; Wei X; Fujiwara M; Robek MD
J Virol; 2014 Sep; 88(18):10909-17. PubMed ID: 25008938
[TBL] [Abstract][Full Text] [Related]
16. Matrix protein of VSV New Jersey serotype containing methionine to arginine substitutions at positions 48 and 51 allows near-normal host cell gene expression.
Kim GN; Kang CY
Virology; 2007 Jan; 357(1):41-53. PubMed ID: 16962155
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitors potentiate vesicular stomatitis virus oncolysis in prostate cancer cells by modulating NF-κB-dependent autophagy.
Shulak L; Beljanski V; Chiang C; Dutta SM; Van Grevenynghe J; Belgnaoui SM; Nguyên TL; Di Lenardo T; Semmes OJ; Lin R; Hiscott J
J Virol; 2014 Mar; 88(5):2927-40. PubMed ID: 24371063
[TBL] [Abstract][Full Text] [Related]
18. Oncolytic vesicular stomatitis virus and bortezomib are antagonistic against myeloma cells in vitro but have additive anti-myeloma activity in vivo.
Yarde DN; Nace RA; Russell SJ
Exp Hematol; 2013 Dec; 41(12):1038-49. PubMed ID: 24067362
[TBL] [Abstract][Full Text] [Related]
19. Molecular determinants of susceptibility to oncolytic vesicular stomatitis virus in pancreatic adenocarcinoma.
Blackham AU; Northrup SA; Willingham M; Sirintrapun J; Russell GB; Lyles DS; Stewart JH
J Surg Res; 2014 Apr; 187(2):412-26. PubMed ID: 24252853
[TBL] [Abstract][Full Text] [Related]
20. Independent of plasmacytoid dendritic cell (pDC) infection, pDC triggered by virus-infected cells mount enhanced type I IFN responses of different composition as opposed to pDC stimulated with free virus.
Frenz T; Graalmann L; Detje CN; Döring M; Grabski E; Scheu S; Kalinke U
J Immunol; 2014 Sep; 193(5):2496-503. PubMed ID: 25070849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
